ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.00
-0.46 (-6.17%)
At close: Jul 17, 2026, 4:00 PM EDT
6.79
-0.21 (-3.00%)
Pre-market: Jul 20, 2026, 4:03 AM EDT
ARS Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, ARS Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $26.75. The average 1-year stock price forecast is 282.14% higher than the current stock price, while the lowest is $21 (+200.00%) and the highest is $32 (+357.14%).
Price Target: $26.75 (+282.14%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ARS Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 5 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $30 | Buy | Maintains | $30 | +328.57% | Jun 25, 2026 |
| Northland Securities | Northland Securities | Buy Maintains $25 | Buy | Maintains | $25 | +257.14% | Apr 15, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $30 | Buy | Reiterates | $30 | +328.57% | Apr 14, 2026 |
Financial Forecast
Revenue This Year
139.84M
from 84.28M
Increased by 65.93%
Revenue Next Year
245.77M
from 139.84M
Increased by 75.75%
EPS This Year
-1.72
from -1.74
EPS Next Year
-0.94
from -1.72
EPS and Forward PE are based on non-GAAP adjusted numbers.